Skull Immune Structures May Provide First Response Against Brain Cancer
For decades, scientists assumed that the brain and the immune system did not communicate. A study by researchers at Washington University School of Medicine (WashU Medicine) in St. Louis has now revealed that the...
Gene Switch Uses Electromagnetic Fields to Control Genes Remotely
Researchers say gene switches currently offer limited temporal and spatial precision and can also have adverse effects. Now, a recent study, “Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression”...
Embedding Regulatory Strategy in Cell and Gene Therapy Development
Register Now
Jeffrey Mocny, PhD VP Scientific LeadershipRose BioSolutions View Bio
Panelist ...
Malaria Mosquito Bites Turned Into Immune Boosters in New Chemovaccination Strategy
More than 600,000 people—predominantly pregnant women and children under the age of five—die from malaria every year. According to the World Health Organization, one child in Africa dies from malaria every two minutes.
Plasmodium parasites...
CDMOs Expand and Build for Future Growth
The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how to incorporate artificial intelligence (AI) into their operations. Following is...
BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris
Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished goods manufacturing from late development through launch. Recursion, Roche, and...
SFA Spectroscopy Chases Away Cloudy Samples
Brendan Darby, PhDCo-founder and CEOMarama LabsCharacterizing the RNA and ligands in nanoparticle-based therapeutics has, historically, been a cumbersome process. The lipid nanoparticles (LNPs) that encase RNA and payloads are cloudy by nature, which means...
Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s Therapy
Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study, the Parkinson’s Precision Medicine Initiative (PPMI). The resulting data are...
In Vivo Protein Generation Using Nanoparticle Delivery: Emerging Platforms and CMC Strategies
Register Now
Tao (Tony) Li, PhD Senior Director, Head of mRNA & Nanoparticle PlatformWuXi Biologics View Bio
Panelist...
The State of Biotech 2026
John Maraganore, PhD Co-Founder and Executive ChairCity Therapeutics View Bio
Panelist ...
